TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression

被引:0
|
作者
Ka-wing Fong
Jonathan C. Zhao
Bing Song
Bin Zheng
Jindan Yu
机构
[1] Northwestern University Feinberg School of Medicine,Division of Hematology/Oncology, Department of Medicine
[2] Northwestern University Feinberg School of Medicine,Department of Biochemistry and Molecular Genetics
[3] Robert H. Lurie Comprehensive Cancer Center,undefined
[4] Northwestern University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
TRIM24 is an effector substrate of the E3 ubiquitin ligase adaptor SPOP and becomes stabilized in prostate cancer (PCa) with SPOP mutations. However, how TRIM24 protein is regulated in the vast majority of SPOP-wildtype PCa is unknown. Here we report TRIM28 as a critical upstream regulator of TRIM24. TRIM28 protein interacts with TRIM24 to prevent its ubiquitination and degradation by SPOP. Further, TRIM28 facilitates TRIM24 occupancy on the chromatin and, like TRIM24, augments AR signaling. TRIM28 promotes PCa cell proliferation in vitro and xenograft tumor growth in vivo. Importantly, TRIM28 is upregulated in aggressive PCa and associated with elevated levels of TRIM24 and worse clinical outcome. TRIM24 and AR coactivated gene signature of SPOP-mutant PCa is similarly activated in human PCa with high TRIM28 expression. Taken together, this study provides a novel mechanism to broad TRIM24 protein stabilization and establishes TRIM28 as a promising therapeutic target.
引用
收藏
相关论文
共 50 条
  • [41] TRIM28 inhibits alternative lengthening of telomere phenotypes by protecting SETDB1 from degradation
    Wang, Chuanle
    Zhou Songyang
    Huang, Yan
    CELL AND BIOSCIENCE, 2021, 11 (01):
  • [42] TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
    Ma, Xiaoxiao
    Jia, Shuqin
    Wang, Gangjian
    Liang, Min
    Guo, Ting
    Du, Hong
    Li, Sisi
    Li, Xiaomei
    Huangfu, Longtao
    Guo, Jianping
    Xing, Xiaofang
    Ji, Jiafu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [43] TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
    Xiaoxiao Ma
    Shuqin Jia
    Gangjian Wang
    Min Liang
    Ting Guo
    Hong Du
    Sisi Li
    Xiaomei Li
    Longtao Huangfu
    Jianping Guo
    Xiaofang Xing
    Jiafu Ji
    Signal Transduction and Targeted Therapy, 8
  • [44] RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation
    Li, C. -W.
    Zheng, J.
    Deng, G. -Q.
    Zhang, Y. -G.
    Du, Y.
    Jiang, H. -Y.
    CANCER SCIENCE, 2024, 115 (11) : 3829 - 3829
  • [45] Epigenetic silencing of miR-137 induces resistance to bicalutamide by targeting TRIM24 in prostate cancer cells
    Guan, Yonghui
    Guan, Xiaoyue
    An, Hengqing
    Baihetiya, Azhati
    Wang, Wenguang
    Shao, Weimin
    Yang, Haiou
    Wang, Yujie
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (05): : 3226 - 3237
  • [46] TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
    Zhang, L-H
    Yin, A-A
    Cheng, J-X
    Huang, H-Y
    Li, X-M
    Zhang, Y-Q
    Han, N.
    Zhang, X.
    ONCOGENE, 2015, 34 (05) : 600 - 610
  • [47] TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
    L-H Zhang
    A-A Yin
    J-X Cheng
    H-Y Huang
    X-M Li
    Y-Q Zhang
    N Han
    X Zhang
    Oncogene, 2015, 34 : 600 - 610
  • [48] SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
    Jian Ma
    Kun Chang
    Jingtao Peng
    Qing Shi
    Hualei Gan
    Kun Gao
    Kai Feng
    Fujiang Xu
    Hailiang Zhang
    Bo Dai
    Yao Zhu
    Guohai Shi
    Yijun Shen
    Yiping Zhu
    Xiaojian Qin
    Yao Li
    Pingzhao Zhang
    Dingwei Ye
    Chenji Wang
    Journal of Experimental & Clinical Cancer Research, 37
  • [49] SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
    Ma, Jian
    Chang, Kun
    Peng, Jingtao
    Shi, Qing
    Gan, Hualei
    Gao, Kun
    Feng, Kai
    Xu, Fujiang
    Zhang, Hailiang
    Dai, Bo
    Zhu, Yao
    Shi, Guohai
    Shen, Yijun
    Zhu, Yiping
    Qin, Xiaojian
    Li, Yao
    Zhang, Pingzhao
    Ye, Dingwei
    Wang, Chenji
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [50] Therapeutic effects of human anti-prostate-specific membrane antigen antibody mediated TRIM24 siRNA delivery in CRPC
    Shi, S.
    Han, D.
    Wu, J.
    Yang, A.
    Qin, W.
    Wen, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1740 - 1740